{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:19:36Z","timestamp":1790965176266,"version":"4.1.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aimed to explore the association between central obesity and disease-specific activity, functional impairment, and patient-reported outcomes (PROMs) in a real-world cohort of individuals with psoriatic arthritis (PsA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a cross-sectional observational study at a tertiary rheumatology outpatient clinic. Adult patients with PsA, diagnosed according to the CASPAR criteria, underwent a multidimensional assessment by a multidisciplinary team. Clinical and pharmacological data, anthropometric measures, disease activity indices (DAPSA and CRP), and PROMs (FACIT-F, PHQ-9, HAQ, PsAID) were collected. Central obesity was defined by waist circumference (\u226588\u202fcm in women, \u2265102\u202fcm in men). Multivariable regression analyses were performed to investigate associations between central obesity and clinical outcomes, adjusting for age, sex, disease duration, and antirheumatic therapies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 158 patients (54.4% female; median age 55.4\u202fyears), central obesity was present in 70.2% of the group. Patients with central obesity had significantly higher inflammatory markers (CRP), increased disease activity (DAPSA), and worse scores across all PROMs compared to those without. In multivariable models, central obesity remained independently linked to disease activity and worse physical and psychosocial outcomes, including fatigue, depression, disability, and disease impact.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Central obesity is a significant and independent predictor of disease severity and patient-reported disability in individuals with Psa. These findings highlight the clinical importance of routinely measuring waist circumference in PsA management and suggest that targeted interventions addressing visceral adiposity could enhance both inflammatory and quality-of-life outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1684641","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:30:57Z","timestamp":1759383057000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Central obesity in psoriatic arthritis: associations with disease activity, function, and quality of life in a real-world cohort"],"prefix":"10.3389","volume":"12","author":[{"given":"Salvatore","family":"Corrao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Scibetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika Lo","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Mallaci Bocchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Natoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Montalbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignazio","family":"Cangemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiano","family":"Argano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jaad.2021.09.019","article-title":"Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: retrospective analysis of an electronic health records database in the United States","volume":"86","author":"Merola","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.4081\/reumatismo.2012.66","article-title":"Epidemiology of psoriatic arthritis","volume":"64","author":"Catanoso","year":"2012","journal-title":"Reumatismo"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/pds.3447","article-title":"Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009","volume":"22","author":"Asgari","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1111\/ajd.13484","article-title":"Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity?","volume":"62","author":"Vastarella","year":"2021","journal-title":"Australas J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1759720X21998279","DOI":"10.1177\/1759720X21998279","article-title":"Psoriatic arthritis and the association with cardiometabolic disease: a narrative review","volume":"13","author":"Karmacharya","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e000588","DOI":"10.1136\/rmdopen-2017-000588","article-title":"Real-world burden of comorbidities in US patients with psoriatic arthritis","volume":"3","author":"Shah","year":"2017","journal-title":"RMD Open"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"a00305","DOI":"10.1177\/247553031117a00305","article-title":"Increased prevalence of sleep disorders and medical comorbidities in psoriatic arthritis patients compared with patients with and without psoriasis","author":"Wong","year":"2011","journal-title":"Psoriasis Forum"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2478\/amma-2014-0041","article-title":"Prevalence of metabolic syndrome in psoriatic arthritis and rheumatoid arthritis","volume":"60","author":"Cr\u0103ciun","year":"2014","journal-title":"Acta Med Marisiensis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"091","DOI":"10.23937\/2469-5726\/1510091","article-title":"Anxiety and depression in psoriatic arthritis: a cross-sectional study in Brazilian patients","volume":"7","author":"Cirpiani","year":"2021","journal-title":"J Rheum Dis Treat"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11926-004-0042-z","article-title":"Development of diagnostic criteria for psoriatic arthritis: methods and process","volume":"6","author":"Taylor","year":"2004","journal-title":"Curr Rheumatol Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"960","DOI":"10.3899\/jrheum.141537","article-title":"Summary of sensitivity and specificity for psoriatic arthritis in a south African cohort according to classification criteria","volume":"42","author":"Maharaj","year":"2015","journal-title":"J Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1002\/art.34536","article-title":"Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritis","volume":"64","author":"Coates","year":"2012","journal-title":"Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/acr.20627","article-title":"Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis","volume":"63","author":"Husted","year":"2011","journal-title":"Arthritis Care Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13075-019-1810-5","article-title":"Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study","volume":"21","author":"Klingberg","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13075-020-02350-5","article-title":"Weight loss is associated with sustained improvement of disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity: a prospective intervention study with two years of follow-up","volume":"22","author":"Klingberg","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1159\/000455840","article-title":"Psoriasis and obesity","volume":"232","author":"Jensen","year":"2016","journal-title":"Dermatology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"528","DOI":"10.5694\/mja2.50591","article-title":"Beyond skin deep: addressing comorbidities in psoriasis","volume":"212","author":"Kovitwanichkanont","year":"2020","journal-title":"Med J Aust"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamadermatol.2018.1412","article-title":"Dietary recommendations for adults with psoriasis or psoriatic arthritis from the medical Board of the National Psoriasis Foundation: a systematic review","volume":"154","author":"Ford","year":"2018","journal-title":"JAMA Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1111\/dom.15467","article-title":"The critical role of abdominal obesity as a crucial cardiovascular risk factor","volume":"26","author":"Corrao","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"573.e1","DOI":"10.1016\/j.jaad.2005.03.046","article-title":"Epidemiology of psoriatic arthritis in the population of the United States","volume":"53","author":"Gelfand","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/j.1468-3083.2009.03463.x","article-title":"The risk of psoriatic arthritis remains constant following initial diagnosis of psoriasis among patients seen in European dermatology clinics","volume":"24","author":"Christophers","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40744-022-00502-4","article-title":"Discrepancy in metabolic syndrome between psoriatic arthritis and rheumatoid arthritis: a direct comparison of two cohorts in one center","volume":"10","author":"Li","year":"2023","journal-title":"Rheumatol Ther"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"e0004","DOI":"10.5041\/RMMJ.10279","article-title":"Comorbidities in patients with psoriatic arthritis","volume":"8","author":"Haddad","year":"2017","journal-title":"Rambam Maimonides Med J"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40744-020-00215-6","article-title":"Obesity and psoriatic arthritis: a narrative review","volume":"7","author":"Kumthekar","year":"2020","journal-title":"Rheumatol Ther"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/diseases13020042","article-title":"The role of cortisol and Dehydroepiandrosterone in obesity, pain, and aging","volume":"13","author":"Erceg","year":"2025","journal-title":"Diseases"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"590749","DOI":"10.3389\/fimmu.2020.590749","article-title":"Adipokines, cardiovascular risk, and therapeutic management in obesity and psoriatic arthritis","volume":"11","author":"Porta","year":"2021","journal-title":"Front Immunol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"6390","DOI":"10.3390\/ijms24076390","article-title":"The role of Adipokines in the pathogenesis of psoriasis","volume":"24","author":"Kie\u0142bowski","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13075-023-03105-8","article-title":"Serum IL-23 significantly decreased in obese patients with psoriatic arthritis six months after a structured weight loss intervention","volume":"25","author":"Landgren","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s42358-025-00444-9","article-title":"Health-related quality of life significantly improved in obese patients with psoriatic arthritis one year after a structured weight loss intervention","volume":"65","author":"Landgren","year":"2025","journal-title":"Adv Rheumatol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s40744-025-00758-6","article-title":"The relationship between metabolic syndrome and pain catastrophizing in psoriatic arthritis","volume":"12","author":"Currado","year":"2025","journal-title":"Rheumatol Ther"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3389\/fendo.2019.00900","article-title":"Association between obesity type and common vascular and metabolic diseases: a cross-sectional study","volume":"10","author":"Zhang","year":"2020","journal-title":"Front Endocrinol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1160\/TH12-09-0703","article-title":"The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance","volume":"109","author":"Chmelar","year":"2013","journal-title":"Thromb Haemost"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1096\/fj.09-151340","article-title":"JNK1 and IKK\u03b2: molecular links between obesity and metabolic dysfunction","volume":"24","author":"Solinas","year":"2010","journal-title":"FASEB J"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.2147\/DMSO.S279837","article-title":"Magnitude of central obesity and its associated factors among adults in urban areas of Northwest Ethiopia","volume":"13","author":"Molla","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1507\/endocrj.K06-210","article-title":"Is central obesity a good predictor of carotid atherosclerosis in Japanese type 2 diabetes with metabolic syndrome?","volume":"54","author":"Yasuda","year":"2007","journal-title":"Endocr J"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-nutr-071811-150623","article-title":"Mechanisms of inflammatory responses in obese adipose tissue","volume":"32","author":"Sun","year":"2012","journal-title":"Annu Rev Nutr"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.2337\/db06-1656","article-title":"Visceral fat adipokine secretion is associated with systemic inflammation in obese humans","volume":"56","author":"Fontana","year":"2007","journal-title":"Diabetes"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2183\/pjab.86.131","article-title":"Establishment of a concept of visceral fat syndrome and discovery of adiponectin","volume":"86","author":"Matsuzawa","year":"2010","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1684641\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T05:30:58Z","timestamp":1759383058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1684641\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":39,"alternative-id":["10.3389\/fmed.2025.1684641"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1684641","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"article-number":"1684641"}}